Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company developing bifunctional therapies for solid tumors. Its lead candidate, ficerafusp alfa, targets EGFR and TGF-β pathways in cancers such as head and neck squamous cell carcinoma.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.